Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028

NEW YORK, Sept. 27, 2018 /PRNewswire/ -- Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs

Read the full report: https://www.reportlinker.com/p05574228

The global ophthalmic drugs market was valued at $23bn in 2017. The market was dominated by the Retinal Disorder drug submarket which held 39.1% of the global ophthalmic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 223-page report you will receive 83 tables and 71 figures- all unavailable elsewhere.
The 223-page report provides clear detailed insight into the top ophthalmic drugs manufacturers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
- Global ophthalmic drugs market revenue forecasts from 2018-2028
- Global ophthalmic drugs market revenue orecasts from 2018-2028, by submarket:
- Retinal Disorder Drugs
- Allergic, Inflammatory & Infective Drugs
- Glaucoma Drugs
- Dry Eye Drugs
- Other Ophthalmic Drugs
- Revenue forecasts from 2018-2028 of the leading ophthalmic drugs:
- Alphagan
- Avastin
- Azopt
- Eylea
- Lucentis
- Lumigan & Ganfort
- Other Ophthalmic Drugs
- Restasis
- Vigamix
- Xalatan/Xalacom
- Our study discusses the selected leading companies that are the major players in the ophthalmic drugs industry:
- Acucela
- Akorn
- Alimera Sciences
- Allergan
- Amakem
- Bayer
- Chengdu Kanghong
- EyeGate Pharmaceuticals
- Gene Signal
- Icon Biosciences
- MacuCLEAR
- Neurotech
- Novartis
- Omeros
- Ophthotech
- Otsuka Pharmaceutical
- Pfizer
- pSivida Corp.
- Regeneron
- Roche
- Santen
- Senju
- Shire
- ThromboGenics
- Valeant
- Our report provides an overview, revenue forecast from 2018-2028 of the ophthalmic drugs segment, revenue forecast from 2018-2028 of the leading drugs, product pipeline and SWOT Analysis, for these companies:
- Akorn
- Alcon
- Allergan
- Bausch & Lomb
- Bayer
- Novartis
- Pfizer
- Regeneron
- Roche
- Santen
- Senju
- Valeant
- Our report provides these Qualitative Analysis:
- Drivers and Restraints of the Global Ophthalmic Drugs market
- SWOT Analysis of selected leading companies
- Porter's Five Forces Analysis of the Global Ophthalmic Drugs Market

Read the full report: https://www.reportlinker.com/p05574228

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com